ArriVent BioPharma Inc.
AVBP | NASDAQ
$30.30
+$0.56 (+1.88%)
Sep 22, 2026, 12:52 PM ET · Market open
TTM Period Ending | TTM 2026 Jun 29, 2026 | TTM 2026 Mar 30, 2026 | TTM 2025 Dec 30, 2025 | TTM 2025 Sep 29, 2025 | TTM 2025 Jun 29, 2025 | TTM 2025 Mar 30, 2025 | TTM 2024 Dec 30, 2024 | TTM 2024 Sep 29, 2024 | TTM 2024 Jun 29, 2024 | TTM 2024 Mar 30, 2024 | TTM 2023 Dec 30, 2023 | TTM 2023 Sep 29, 2023 | TTM 2023 Jun 29, 2023 | TTM 2023 Mar 30, 2023 | TTM 2022 Dec 30, 2022 | TTM 2022 Sep 29, 2022 | TTM 2021 Dec 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PE Ratio | -9.44 | -6.54 | -4.50 | -4.35 | -5.42 | -4.90 | -11.15 | -9.75 | -8.14 | -8.25 | -9.71 | -11.49 | -12.05 | -2.95 | -1.64 | -1.68 | -0.49 |
PEG Ratio | -1.01 | -0.46 | -3.74 | 0.56 | 0.10 | -0.02 | n/a | 1.58 | -0.33 | 0.47 | -0.21 | 0.35 | -0.15 | -0.18 | 0.14 | 0.02 | n/a |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 3.19 | 2.83 | 2.80 | 3.04 | 3.12 | 2.87 | 2.57 | 2.81 | 3.08 | 3.46 | 3.94 | 3.79 | 2.82 | 1.92 | 1.11 | 0.21 | 0.62 |
P/FCF Ratio | -11.18 | -7.73 | -4.82 | -5.29 | -6.02 | -5.24 | -12.74 | -11.44 | -8.93 | -10.65 | -12 | -11.79 | -13.06 | -15.69 | -25.95 | -67.49 | -2.03 |
P/OCF Ratio | -11.18 | -7.73 | -4.82 | -5.29 | -6.02 | -5.24 | -12.74 | -11.44 | -8.93 | -10.65 | -12 | -11.79 | -13.06 | -15.69 | -25.95 | -67.49 | -2.03 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | n/a | n/a |
Quick Ratio | 13.96 | 13.61 | 13.70 | 13.78 | 14.88 | 18.07 | 22.69 | 22.84 | 22.48 | 19.98 | 11.77 | 13.79 | 9.34 | 5.46 | 5.46 | n/a | 23.63 |
Current Ratio | 13.96 | 13.61 | 13.70 | 13.78 | 14.88 | 18.07 | 22.69 | 22.84 | 22.48 | 19.98 | 11.77 | 13.79 | 9.34 | 5.46 | 5.46 | n/a | 23.63 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -12.50% | -12.24% | -16.85% | -15.96% | -14.94% | -13.65% | -7.07% | -8.57% | -8.81% | -9.87% | -10.24% | -8.23% | -6.14% | -3.24% | -5.95% | -5.94% | -125.19% |
Return on Assets | -11.61% | -11.36% | -15.73% | -14.94% | -14.01% | -12.87% | -6.73% | -8.10% | -8.33% | -9.27% | -7.94% | -6.12% | -4.14% | -1.43% | -1.43% | n/a | -119.91% |
Return on Invested Capital | -13.44% | -13.22% | -17.90% | -17.04% | -16.08% | -14.88% | -8.27% | -9.78% | -10.03% | -10.90% | -9.28% | -6.96% | -4.53% | -1.50% | -1.50% | n/a | -21.10% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove AVBP